Clinical Trial Update: Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating endoscopic ablation for atrial fibrillation in patients who failed drug therapy was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Endoscopic ablation system

Snippet

Sponsor: CardioFocus | Conditions: Atrial Fibrillation | Phase 3 | Status: TERMINATED | Results posted: 2012-06-27